title: A patient with tremor, part 2: from diagnosis to treatment.
authors.affiliation: Movement Disorders Program, Division of Neurology, University of Western Ontario, London, Ont. rishi_medicine@yahoo.com
authors.forename: Hrishikesh
authors.initials: H
authors.lastname: Kumar
authors.forename: Mandar
authors.initials: M
authors.lastname: Jog
mesh_terms: D000328:Adult; D000368:Aged; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D002524:Cerebellar Ataxia / Q000150:complications / Q000175:diagnosis; D018450:Disease Progression; D004244:Dizziness / Q000175:diagnosis* / Q000628:therapy; D020821:Dystonic Disorders / Q000175:diagnosis; D004576:Electromyography; D020329:Essential Tremor / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010300:Parkinson Disease / Q000175:diagnosis; D013971:Thyrotoxicosis / Q000150:complications / Q000175:diagnosis*; D014202:Tremor / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014811:Vitamin E Deficiency / Q000150:complications
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins